Use of Granulocyte-colony Stimulating Factor During Chemotherapy and Its Association With CA27.29 and Circulating Tumor Cells—Results From the SUCCESS A Trial

The present study examined the association between granulocyte colony-stimulating factor (G-CSF) and prognostic markers cancer antigen (CA)27.29 and circulating tumor cells (CTCs) in 2646 early-stage breast cancer patients. Those with G-CSF application showed a significantly greater increase in CA27...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical breast cancer 2018-10, Vol.18 (5), p.e1103-e1110
Hauptverfasser:	Hepp, Philip, Fasching, Peter A., Beckmann, Matthias W., Fehm, Tanja, Salmen, Jessica, Hagenbeck, Carsten, Jäger, Bernadette, Widschwendter, Peter, de Gregorio, Nikolaus, Schochter, Fabienne, Mahner, Sven, Harbeck, Nadia, Weissenbacher, Tobias, Kurt, Ayse-Gül, Friedl, Thomas W.P., Janni, Wolfgang, Rack, Brigitte
Format:	Artikel
Sprache:	eng
Schlagworte:	Adjuvant chemotherapy Adult Aged Antigens, Tumor-Associated, Carbohydrate - blood Antigens, Tumor-Associated, Carbohydrate - drug effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biomarkers, Tumor - blood Breast Neoplasms - blood Breast Neoplasms - drug therapy Chemotherapy, Adjuvant - methods Clinical Trials as Topic CTCs Early breast cancer Female G-CSF Granulocyte Colony-Stimulating Factor - administration & dosage Humans Middle Aged Neoplastic Cells, Circulating - drug effects Retrospective Studies Tumor marker flare up Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!